Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Explore which bond type—Treasury or corporate—typically incurs lower taxes in retirement and how that shapes your income strategy.
28,027 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A university dean warns that AI's push for efficiency could erase entry-level roles for young workers, even as they d...
A new advocacy group backing Kalshi’s prediction market efforts has publicly launched in Washington, with former Whit...
Drew Barrymore’s 280-year-old Westchester weekend retreat has secured a buyer, after listing for $4.99 million. The d...
A focused look at a large institutional bet on Indivior, the logic behind the $143 million investment, and how such m...
A handful of the nation’s most fervent sports markets chose not to bid for hosting World Cup games in 2026, citing fi...
Investors are weighing SpaceX IPO buzz against a broader rotation into blue chips, with traders signaling a shift awa...
As the Fed signals potential slower rate moves, tech stocks gyrate. The standout is a cash-generating giant deliverin...
Bitcoin traders eye a potential rally as Trump hints at a durable Iran agreement. Markets are watching whether will r...
A Tuesday hearing in Luigi Mangione’s case was postponed after prosecutors failed to inform jail staff, underscoring ...
As U.S. markets navigate mixed inflation data and a cautious Fed stance, dividends remain a focal point. This report ...
A Portland, Oregon court filing shows Compass has settled the Murch TCPA lawsuit. The terms are confidential, and a n...